145 related articles for article (PubMed ID: 35813301)
21. Impact of the Receptor for Advanced Glycation End Products Genetic Polymorphisms on the Progression in Uterine Cervical Cancer.
Lee CY; Ng SC; Hsiao YH; Yang SF; Hsu CF; Wang PH
J Cancer; 2018; 9(21):3886-3893. PubMed ID: 30410591
[TBL] [Abstract][Full Text] [Related]
22. Impact of Genetic Variants of Long Noncoding RNA
Sun YH; Chou YH; Tsai HY; Hsiao YH; Lee CY; Yang SF; Ting KH; Wang PH
J Cancer; 2022; 13(7):2150-2158. PubMed ID: 35517413
[TBL] [Abstract][Full Text] [Related]
23. Involvement of endothelial nitric oxide synthase gene variants in the aggressiveness of uterine cervical cancer.
Hung WC; Wu TF; Ng SC; Lee YC; Shen HP; Yang SF; Wang PH
J Cancer; 2019; 10(12):2594-2600. PubMed ID: 31258766
[TBL] [Abstract][Full Text] [Related]
24. Association of single-nucleotide polymorphisms of high-mobility group box 1 with susceptibility and clinicopathological characteristics of uterine cervical neoplasia in Taiwanese women.
Wu HH; Liu YF; Yang SF; Lin WL; Chen SC; Han CP; Wang HL; Lin LY; Wang PH
Tumour Biol; 2016 Oct; ():. PubMed ID: 27704361
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.
Peterson NB; Beeghly-Fadiel A; Gao YT; Long J; Cai Q; Shu XO; Zheng W
Int J Cancer; 2009 Aug; 125(4):844-50. PubMed ID: 19431211
[TBL] [Abstract][Full Text] [Related]
26. Impacts of single nucleotide polymorphisms in three microRNAs (miR-146a, miR-196a2 and miR-499) on the susceptibility to cervical cancer among Indian women.
Thakur N; Singhal P; Mehrotra R; Bharadwaj M
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30872409
[No Abstract] [Full Text] [Related]
27. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
28. Correlation of chitinase 3-like 1 single nucleotide polymorphisms and haplotypes with uterine cervical cancer in Taiwanese women.
Lin YS; Liu YF; Chou YE; Yang SF; Chien MH; Wu CH; Chou CH; Cheng CW; Wang PH
PLoS One; 2014; 9(9):e104038. PubMed ID: 25203433
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of human nonmetastatic clone 23 type 1 gene and neoplastic lesions of uterine cervix.
Feng CY; Wang PH; Tsai HT; Tee YT; Ko JL; Chen SC; Lin CY; Han CP; Yang JS; Liu YF; Lin LY; Yang SF
Reprod Sci; 2010 Oct; 17(10):886-93. PubMed ID: 20601538
[TBL] [Abstract][Full Text] [Related]
30. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
31. TIMP3 Gene Polymorphisms of -1296 T > C and -915 A > G Increase the Susceptibility to Arsenic-Induced Skin Cancer: A Cohort Study and In Silico Analysis of Mutation Impacts.
Wu MM; Chen CW; Chen CY; Lee CH; Chou M; Hsu LI; Lee TC; Chen CJ
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499314
[TBL] [Abstract][Full Text] [Related]
32. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
33. The eIF3a Arg803Lys genetic polymorphism is associated with susceptibility to and chemoradiotherapy efficacy in cervical carcinoma.
Xu JZ; Wen F; Wang XR
Kaohsiung J Med Sci; 2017 Apr; 33(4):187-194. PubMed ID: 28359406
[TBL] [Abstract][Full Text] [Related]
34. Impact of
Sun YH; Chen LJ; Wang CH; Lee CY; Hsiao YH; Yang SF; Wang PH
J Cancer; 2023; 14(13):2529-2537. PubMed ID: 37670967
[TBL] [Abstract][Full Text] [Related]
35. G801A polymorphism of human stromal cell-derived factor 1 gene raises no susceptibility to neoplastic lesions of uterine cervix.
Tee YT; Yang SF; Wang PH; Tsai HT; Lin LY; Lee SK; Liao CL; Chang JT; Shih YT
Int J Gynecol Cancer; 2012 Oct; 22(8):1297-302. PubMed ID: 22954782
[TBL] [Abstract][Full Text] [Related]
36. Significant relation of tissue inhibitor of matrix metalloproteinase-2 and its combination with matrix metalloproteinase-2 to survival of patients with cancer of uterine cervix.
Wang PH; Ko JL; Yang SF; Tsai HT; Tee YT; Han CP; Lin LY; Chen SC; Shih YT
Reprod Sci; 2011 Aug; 18(8):798-808. PubMed ID: 21422052
[TBL] [Abstract][Full Text] [Related]
37. Correlations of Galectin-3 Gene Polymorphisms with Risk and Prognosis of Cervical Cancer in Chinese Populations: A Case-Control Study.
Fang SQ; Feng YM; Li M
Oncol Res Treat; 2017; 40(9):533-539. PubMed ID: 28848207
[TBL] [Abstract][Full Text] [Related]
38. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
40. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
